How I treat myelodysplastic syndromes

被引：0
作者：
Zhao, Lin-Pierre [1 ,2 ,3 ]
Sebert, Marie [1 ,2 ,4 ]
机构：
[1] Univ Paris Cite, IRSL, Paris, France
[2] Hop St Louis, AP HP, Serv Hematol Clin, Paris, France
[3] INSERM, UMR 1160, Paris, France
[4] CNRS, UMR7212, INSERM, U944, Paris, France
来源：
HEMATOLOGIE | 2023年 / 29卷 / 05期
关键词：
ACUTE MYELOID-LEUKEMIA; HEALTH-ORGANIZATION CLASSIFICATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; RANDOMIZED PHASE-III; LOWER-RISK MDS; INTENSIVE CHEMOTHERAPY; PROGNOSTIC IMPACT;
D O I：
10.1684/hma.2023.1823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Myelodysplastic syndromes (MDS) are clonal myeloid haemopathies mainly affecting elderly subjects. The recently updated international classifications of the World Health Organisation and the International Consensus Classification now distinguish MDS on the basis of cytological abnormalities (excess blasts) and their genetic profile. Prognostic stratification of patients is essential to guide therapeutic management, the aim of which is to improve symptoms and quality of life in patients with low-risk MDS, or to slow leukaemic transformation in high-risk patients. Therapeutic options have evolved in recent years, with the appearance of new compounds that have obtained marketing authorisation (luspatercept), and other promising targeted therapies (isocitrate dehydrogenase inhibitor, venetoclax), the development of which has been based on a better understanding of the biology of MDS.
引用
收藏
页码：303 / 315
页数：13
相关论文
共 107 条
  • [1] Ades L, 2022, Blood Adv
  • [2] Enasidenib (ENA) Is Effective in Patients with IDH2 Mutated Myelodysplastic Syndrome (MDS) : The Ideal Phase 2 Study By the GFM Group
    Ades, Lionel
    Dimicoli-Salazar, Sophie
    Sebert, Marie
    Cluzeau, Thomas
    Bastard, Aspasia Stamatoulas
    Laribi, Kamel
    Fossard, Gaelle
    Itzykson, Raphael
    Rauzy, Odile Beyne
    Garnier, Alice
    Gloaguen, Silke
    Vey, Norbert
    Le Jeune, Caroline
    Giagounidis, Aristoteles
    Gyan, Emmanuel
    Perard, Baptiste
    Thepot, Sylvain
    Ojeda, Mario
    Chermat, Fatitha
    Desseaux, Kristell
    Clappier, Emmanuelle
    Chevret, Sylvie
    Platzbecker, Uwe
    Fenaux, Pierre
    [J]. BLOOD, 2021, 138
  • [3] Myelodysplastic syndromes
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    [J]. LANCET, 2014, 383 (9936) : 2239 - 2252
  • [4] Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study
    Alessandrino, Emilio Paolo
    Della Porta, Matteo Giovanni
    Bacigalupo, Andrea
    Malcovati, Luca
    Angelucci, Emanuele
    Van Lint, Maria Teresa
    Falda, Michele
    Onida, Francesco
    Bernardi, Massimo
    Guidi, Stefano
    Lucarelli, Barbarella
    Rambaldi, Alessandro
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Pascutto, Cristiana
    Oneto, Rosi
    Pirolini, Laura
    Fanin, Renato
    Bosi, Alberto
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 476 - 484
  • [5] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial
    Angelucci, Emanuele
    Li, Junmin
    Greenberg, Peter
    Wu, Depei
    Hou, Ming
    Montano Figueroa, Efreen Horacio
    Guadalupe Rodriguez, Maria
    Dong, Xunwei
    Ghosh, Jagannath
    Izquierdo, Miguel
    Garcia-Manero, Guillermo
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) : 513 - +
  • [6] [Anonymous], Aplasies medullaires acquises et constitutionnelles
  • [7] International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert P.
    Borowitz, Michael J.
    Calvo, Katherine R.
    Kvasnicka, Hans-Michael
    Wang, Sa A.
    Bagg, Adam
    Barbui, Tiziano
    Branford, Susan
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    Dal Cin, Paola
    DiNardo, Courtney D.
    Dombret, Herve
    Duncavage, Eric J.
    Ebert, Benjamin L.
    Estey, Elihu H.
    Facchetti, Fabio
    Foucar, Kathryn
    Gangat, Naseema
    Gianelli, Umberto
    Godley, Lucy A.
    Gokbuget, Nicola
    Gotlib, Jason
    Hellstrom-Lindberg, Eva
    Hobbs, Gabriela S.
    Hoffman, Ronald
    Jabbour, Elias J.
    Kiladjian, Jean-Jacques
    Larson, Richard A.
    Le Beau, Michelle M.
    Loh, Mignon L. -C.
    Lowenberg, Bob
    Macintyre, Elizabeth
    Malcovati, Luca
    Mullighan, Charles G.
    Niemeyer, Charlotte
    Odenike, Olatoyosi M.
    Ogawa, Seishi
    Orfao, Alberto
    Papaemmanuil, Elli
    Passamonti, Francesco
    Porkka, Kimmo
    Pui, Ching-Hon
    Radich, Jerald P.
    Reiter, Andreas
    Rozman, Maria
    Rudelius, Martina
    Savona, Michael R.
    [J]. BLOOD, 2022, 140 (11) : 1200 - 1228
  • [8] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [9] Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation
    Armand, Philippe
    Kim, Haesook T.
    Cutler, Corey S.
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    [J]. BLOOD, 2007, 109 (10) : 4586 - 4588
  • [10] Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?
    Baer, Constance
    Huber, Sandra
    Hutter, Stephan
    Meggendorfer, Manja
    Nadarajah, Niroshan
    Walter, Wencke
    Platzbecker, Uwe
    Goetze, Katharina S.
    Kern, Wolfgang
    Haferlach, Torsten
    Hoermann, Gregor
    Haferlach, Claudia
    [J]. LEUKEMIA, 2023, 37 (04) : 938 - 941
12345678910